Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)-Reference-Cited by-同舟云学术

Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)

Published:2014-09-23 Issue:3 Volume:52 Page:289-295
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Chishimba Livingstone,Langridge Philip,Powell Georgina,Niven Robert M.,Denning David W.

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference33 articles.

1. An ongoing Confidential Enquiry into asthma deaths in the Eastern Region of the UK, 2001–2003

2. Death rates for asthma in English populations 1979–2007: Comparison of underlying cause and all certified causes

3. Clinical, economic, and humanistic burden of asthma in Canada: a systematic review

4. Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in ireland 1985–88

5. Immune Response, Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Lung Disease

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aerosolized Antifungals for the Treatment of Pulmonary Fungal Diseases;Current Fungal Infection Reports;2024-04-01

2. Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses;European Respiratory Journal;2024-02-29

3. Poorly controlled asthma – Easy wins and future prospects for addressing fungal allergy;Allergology International;2023-10

4. Efficacy of different durations of antifungal prophylaxis with nebulized amphotericin B after lung transplantation: a retrospective cohort study;Journal of Thoracic Disease;2023-10

5. Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: A systematic review and meta-analysis;Pulmonary Pharmacology & Therapeutics;2023-08